The complete Global Glaucoma Treatment Market - Trends And Opportunities: 2015 Edition spread across 80 pages, profiling 4 companies and supported with 3 tables and 67 figures is now available at http://www.marketreportsonline.com/422741.html .
The global Glaucoma market has been growing rapidly since the past several years mainly due to innovation such as introduction of IOPtiMa, OTP-TX, anti-VEGF therapy, photodynamic therapy (PDT) laser photocoagulation, Rhopressa, latanoprost and Vesneo. Among the several varieties of drugs and surgeries available in the market, the demand for drugs such as Prostaglandins which includes Trabatan, Lumbigan are the highest due to its high efficiency in treating glaucoma. Vesneo has shown a superior intraocular pressure reduction effect on beta-blocker timolol, the most widely used comparator in registration trials for glaucoma, in two phase 3 studies.The report titled “Global Glaucoma Treatment Market: Trends and Opportunities (2015 Edition)” analyzes the potential opportunities, challenges, demand drivers and significant trends representing the Glaucoma treatment market. The report elucidates facts on the glaucoma treatment market as supplemented by the latest available statistics. It also profiles and analyzes the leading four companies operating in this industry with the latest data and a brief overview of their business and financial performance along with a brief discussion of their future business strategies. The glaucoma treatment report gives valuable insight into technology used in glaucoma treatment market, its demand in various geographies. In the report, we also try to study the growth pattern in the prescriptions and revenue earned by the glaucoma treatment companies and the latest trends concerning glaucoma treatment market.
Company Coverage of Glaucoma Treatment Industry: Biolite Israeli, Pfizer Inc., Merck & Co. Inc. & Alcon ( A division of Novartis)
Products Covered: Prostaglandin, Combination Market, Carbonic Anhydrase Inhibitor, Beta Blocker, Alpha Agonist & Cholinergic & Surgical Devices
Purchase a copy of “glaucoma treatment Market” research report at USD 1200 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=422741.
Globally, the major factors contributing to the growth of glaucoma treatment market is the higher number of glaucoma patients from the U.S, Europe and Japan. Novel therapies for glaucoma are constantly being investigated by research and development teams of various pharmaceutical companies, at different stages. It can be predicted that novel therapies that work in conjunction with current drugs, such as Prostaglandins, will likely be increasingly common in the near future.
Growth of the glaucoma treatment market could also be attributed to North America where the number of patients suffering from glaucoma is the highest among the rest of the U.S and also from emerging markets such as France and Singapore driven by rapid increase of old age population. Moreover, the Asian market is expected to become a huge potential market for glaucoma surgery devices in the foreseeable future, as it is expected to grow at comparatively the fastest among all other regions. It is estimated that by 2020, 11 million individuals will have vision loss due to glaucoma.
Glaucoma market is seen as a diversifying risk to other lines of ophthalmic treatment business and is attracting more and more revenue. Glaucoma treatment companies are launching new technologies and adopting new strategies in the industry and making significant investments.
Explore more reports on the Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Connect With Us on:
G+ / Google Plus: https://plus.google.com/108330077369677148621/postsContact Us:
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441